title: Corrigendum re: "Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications" [Eur Urol 2017;71:55-65].
authors.affiliation: Division of Urology, Rhode Island Hospital and The Miriam Hospital, Providence, RI, USA.
authors.forename: Boris
authors.initials: B
authors.lastname: Gershman
authors.affiliation: Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN, USA.
authors.forename: Holly K
authors.initials: HK
authors.lastname: Van Houten
authors.affiliation: Division of Cardiology, Yale University School of Medicine, New Haven, CT, USA; Health Research and Educational Trust, Chicago, IL, USA.
authors.forename: Jeph
authors.initials: J
authors.lastname: Herrin
authors.affiliation: Department of Urology, University of Illinois, Chicago, IL, USA.
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Moreira
authors.affiliation: Department of Urology, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Urology Institute, Cleveland, OH, USA.
authors.forename: Simon P
authors.initials: SP
authors.lastname: Kim
authors.affiliation: Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN, USA; OptumLabs, Cambridge, MA, USA.
authors.forename: Nilay D
authors.initials: ND
authors.lastname: Shah
authors.affiliation: Department of Urology, Mayo Clinic, Rochester, MN, USA. Electronic address: karnes.r@mayo.edu.
authors.forename: R Jeffrey
authors.initials: RJ
authors.lastname: Karnes